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ENHANCE PRODUCTION OF EXTRACELLULAR URATE OXIDASE BY

ASPER GILL US FL4 VUS 
ABSTRACT 
Urate oxidase or uricase is an enzyme that catalyses the oxidation of uric acid to 
allantoin and plays important rule in purine metabolism. The first important application 
discovered for uricase was in clinical biochemistry as diagnosis reagent for measurement 
of uric acid in blood. The precipitation of uric acid can leading to gout symptom. The 
main purpose of this research is to optimize the culture condition for maximum uricase 
production by Aspergillusfiavus. The parameters studied were pH (range of 4 to 8), the 
sucrose concentration (lOg/i to 50 Wi) and the agitation rate (100 to 300 rpm). The 
Aspergillus flavus were inoculated in yeast extract with sucrose and incubated for 24 
hours at 200 rpm and 30°C. The maximum enzyme activity obtained from the 
experiment is 0.03974 U/ml at pH 6, 200 rpm and 30 g/l sucrose concentration. Since 
the optimum conditions were obtained, the production of uricase can be enhanced and 
world demand on uricase can be fulfill in the future. 
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MENINGKATKAN PENGELUARAN EKSTRASELULAR URATE OXIDASE 
OLEH ASPER GILL US FLA VUS 
ABSTRAK 
Urate oksidas atau unease merupakan enzim yang menjadi pemangkin 
pengoksidaan asid urik ke alantoin dan memainkan peranan penting dalam metabolisme 
punin. Aplikasi pertama yang penting ditemui untuk unease adalah dalam biokimia 
klinikal sebagai reagen diagnosis untuk mengukur asid urik dalam darah. Pemendakan 
asid urik boleh membawa kepada gejala penyakit gout. Tujuan utania kajian mi adalah 
untuk mengoptimunikan keadaan kultur pengeluaran unease maksimum oleh 
Aspergillusfiavus. Parameter yang dikaji ialah pH (julat 4-8), kepekatan sukrosa (lOg / 1 
hingga 50 g / 1) dan kadar pengadukan (100-300 rpm). Aspergillus flavus telah 
diinokulasi dalam ekstrak yis dengan sukrosa dan dieram selama 24 jam pada 200 rpm 
dan 30 °C. Aktiviti enzim maksimum diperolehi dari eksperimen tersebut adalah 0, 
03974 U / mL pada pH 6, 200 rpm dan kepekatan sukrosa 30W!. Oleh kerana keadaan 
optimum telah diperolehi, pengeluaran unease boleh dipertingkatkan dan permintaan 
dunia pada uricase boleh dipenuhi pada masa depan. 
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CHAPTER 1 
1.0 INTRODUCTION 
1.1 Background of Proposed Study 
Urate oxidase or uricase is an enzyme that catalyses the oxidation of uric acid to 
allantoin and plays important rule in purine metabolism. This most find in vertebrates. 
The first important application discovered for uricase was in clinical biochemistry as 
diagnosis reagent for measurement of uric acid in blood. The precipitation of uric acid 
can leading to gout symptom. Gout treatment generally includes allopurinol, however 
with direct injection of urate oxidase allow much more rapid resorption of urate 
nephrolithiases. The minimum plasma concentration of uric acid was significantly lower 
after treatment with uricase compared to allopurinol treatment. In this case, uricase is the 
only substrate that can bind to uric acid (Atalla et al., 2009). 
The urate oxidase can be produce by many type of microorganism. About 
nineteen of strains can produce urate oxidase. Atalla et al. (2009) stated that urate
oxidase can be produced from Gliomastix gueg. Chen et al. (2008) proved that urate 
oxidase can be produce from recombinant Hensula polymorpha with three copies of 
expression cassette and selected for process optimization for the production of 
recombinant enzyme. Beside that, bacteria like MicrobacteiuiW alsO can produce urate 
oxidase through purification (Kai et al., 2007). Ho'xever, urate oxidase is commercially 
produced by Aspergillusfiavus (Atalla et al., 2009). 
1.2 Problem Statement 
The uricase is the better way use to treat gout as it allows much more rapid 
resorption of urate nephrolithiases compared to previous method which used allopurinol. 
The uricase is better because it gives more rapid resorption to the gout's patient. The 
researchers also found that, in their study of more than 5,000 people, about 21.4 percent 
had high levels of uric acid in their blood, which is known to be a risk factor for 
developing gout (Retrieved on 27' April 2012 from 
http://www.scientificamerjcan.coniJartjc1ecfm?id=goutonthe .. jse) The number of 
gout's patient increasing rapidly, however the production uricase nowadays still not 
fulfil the demand. 
Even though uricase had been produced by fermentation in previous study, the 
optimum condition that can enhance the maximum production of urate oxidase still in 
study. The best agitation rate, optimum pH value and carbon source concentration is still 
unknown.
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The urate oxidase can be produced from many types of fungal, yeast and 
bacteria. For example, bacteria like Bacillus subtilis can produce uricase. However, this 
bacterium is not thermal stable and it will lost their activities in short period at 
temperature higher than 60 °C (Zhou et al., 2005). Fungal strain is the best 
microorganism because it is easy to manage and less sensitive. Beside that, the fungal 
strain is more stable than other microorganism that can produce uricase. The productions 
of uricase from yeast and bacteria source are highly cost and less production. 
Aspergillus flavus is one of the fungal strain that easily available and less expensive 
compared to other fungus strains. 
1.3 Research Objective 
1.3.1 To screen the optimum parameters (pH, agitation rate and sucrose concentration) 
in order to enhance the production of uricase 
1.4 Scope of Proposed Study 
The research is focusing on fermentation condition that influences the production 
of unease by Aspergillus flavus in shake flask cultures. In order to find the optimum 
condition the experiment was carried out using one factor at a time technique. The 
concentration of sucrose (ranged from 10 to 50 g/l), pH of the fermentation medium 
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(ranged from 4 to 8) and agitation rate (ranged from 100 to 300 rpm) were studied one 
by one in a selected range determined form literature review. 
1.5 Significance of Proposed Study 
The importance of the proposed research is to enhance the maximum production 
of uricase and to fulfil the market demand. Theoretically, the uricase give the better 
effect on gout's patient compared to medicine used nowadays like allopurinol because 
direct injection of urate oxidase allow much more rapid resorption of urate 
nephrolithiases. Beside that, it helps the better life of humankind in the future. The 
available medicine nowadays is too expensive and not all people can afford the price of 
that medicine. Therefore, the fungal strain use in the research is the less expensive and 
the method use is the research also less expensive in order to produce medicine that all 
level of people can afford.
CHAPTER 2 
2.0 LITERATURE REVIEW 
2.1 Unease 
Uricase can be produce from many types of fungus such as Gliomastix gueg, 
Microbaterium and Hansenulapolymorpha ( Atalla et al., 2009, Kai et al., 2008, Chen et 
al.,2008). The first application discovered for uricase was in clinical biochemsistry as 
diagnostic reagent for measurement of uric acid in blood and other biological fluids 
(Atalla et al., 2009). Uricase, which catalyse the oxidation breakdown of uric acid, 
belong to a group of enzyme in the purine degradation pathway in animals, plants, fungi, 
yeast and bacteria (Kai et al., 2008). In December 1991, pharmacodynamic study on 
niethotrexate and mercatopurine before conventional remission induction therapy with 
newly diagnosed acute lymphoblastic leukemia (ALL) with allopurinol used to treat 
hyporuricemia. After finding the effect of allopurinol, the uricase is replaced to treat 
cancer patient (Pui et al., 1997).The urate oxidase can acts as a catalyst in the enzymatic 
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oxidation of uric acid to alla ntion, a readily excreted metabolite that five- to 10- fold 
more soluble than uric acid (Pui et al., 2001). 
2.2 Microbial Production of Unease 
Chevalet et al. (1992) stated Aspergillus fiavus can be the resistance to drugs, 
allow for transformation of any fungal strain that is sensitive to such inhibitors. Beside 
that, Aspergillus flavus is concerned with the complementation of genetic defects, 
among which auxotrophy for arginine or uridine and the mutation affecting nitrate 
assimilation are well known. 
Atalla et al. (2009) stated that microbial enzyme is inducible and therefore, the 
presence of uric acid or some other inducer in the medium is necessary for enzyme 
production. Several microbial sources of uricase have been proposed for this clinical 
indication, only one has actually been used commercially under the trade mark of 
uricozyme and is isolated and purified from Aspergillusfiavus. 
Beside that, Lotfy (2008) studied that Bacillus thermocatenulatus strain can 
produce uricase. The aim of the study is to investigate the ability of Bacillus 
the rmocagenulatus as a novel uricase producer and to optimize the enzyme productivity. 
The strain is quite stable because the aeration rate does not give any changes on 
production rate and growth of the strain.
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PmS 
K+S (2.1) 
Yazdi et al. (2006) stated there is no report exists on the production unease by 
Mucor hiemalis. However, it is necessary to screen the new sources for production of 
unease which more economical, and which may have unique properties to expand its 
usefulness. Therefore, he proved that Mucor hiemalis can prodtice unease. The Mucor 
hiemalis is one of common soil fungi. The study describes the isolation of a strain 
capable of producing relatively high levels of uricase in short time. Optimization of 
medium composition and relevant conditions for enzyme activity are also clarified. 
2.3 Monod equation 
The Monod equation describes substrate-limited growth only when growth is 
slow and population density is low. Figure 2.1 is the relationship of specific growth rate 
to substrate concentration often assumes the form of saturation kinetics. Assume that a 
single chemical species, 5, is growth-rate limiting which mean increase in S influences 
growth rate, while changes in other nutrient concentrations have no effect (Shuler and 
Kargi, 2002). This is quite similar to the Michaelis-Menten kinetics for enzyme 
reactions. Since it applied to cellular systems, this kinetics can be described by the 
Monod equation:
Where; ji specific growth rate, ji = maximum specific growth rate,S= substrate 
concentration (g/l) and K5
 = saturation constant. 
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Maximum specific growth rate, Urn is when S>> K5 . If endogeneous metabolism 
is unimportant, then U net = U the constantKs is known as half-velocity constant and is 
equal to the concentration of the rate limiting substrate when specific rate of growth is 
equal to one-half of the maximum. That is, K5 = S when i=4/2Pm. In general, U = Urn 
for S>> K5 and t(Um11(S)S for S<< K5 . The Monod equation is semiempirical; it 
derives from the premise that a single enzyme system with Michaelis-Menten kinetics is 
responsible for uptake of 5, and the amount of that enzyme or its catalytic activity is 
sufficiently low to be growth-rate limiting. 
Figure 2.1 Substrate-limited growths.

(Source: Shuler and Kargi, 2002) 
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2.4 Factors that Enhance the Production of Uricase 
For the effect of pH of uricase production by Aspergillus flavus, Tohamy and 
Shindia (2002) and Yazdi et.al (2006) agree that pH 6"wa5 the optimum pH for 
AspergillusfiaVus. Beside that, Ammar (1988) reported ,at pH 9.2 was the optimum pH 
for the best production. Chen et al. (2008) stated that the best specific growth rate was 
obtained at pH 5.5 and highest cell-specific uricase production was achieved at pH 6.5, a 
PH control strategy of switching pH value from 5.5 in cell growth phase to 6.5 in 
induction phase was used to improve uricase production. Anderson and Vijayakumar 
(2011) reported highest uricase activity was attained at pH 8.5 and 35 °C using 
Pseudomonas aeruginosa. Beside that, Yazdi et al. (2006) reported that maximum 
production was achieved at pH 6 by Aspergillus terreus. 
The effect of carbon source concentration on uricase production by Aspergillus 
flavus, Atalla et al. (2009) agreed with Abd El Fattah and Abo Hamed (2002) that 
Aspergillus flavus produced the highest amount of uricase in the medium containing 
sucrose. Therefore, the best carbon source is sucrose. However, the best concentration of 
sucrose is still in study. 
Based on literature review, it was found out that until today, there is no study on 
the effect of agitation rate for uricase production. Therefore, this study will focus on the 
effect of agitation rate (rpm) at range 100 to 300. 
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2.5 Production of Uricase 
New crystal-packing contacts in relation to the content of active site can produce 
uricase from Aspergillus flavus. Expression of the recombinant enzyme Saccharomyces 
cerevisiae followed by a new purification procedure allowed the crystallization of both 
unliganded and liganded enzyme utilizing the same condition but in various crystal 
forms. The inhibitor used is chemical (Pascal et al., 2005). 
The uricase also can be produced by extraction. Anderson and Vijayakumar 
(2011) stated that uricase can be produced by extraction using Pseudomonas aeruginosa. 
Then, uricase was purified by ammonium sulphate precipitation. The purified enzyme 
was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE).
The uricase produced from fermentation method by using Gliomastix gueg. The 
fermentation medium used in inoculated flask are uric acid, Czapek dox and yeast 
extract sucrose. The inoculated flasks were incubated on a rotary incubator shaker at 150 
rpm for 8 days at 30 °C after which the mycelium of each isolate was collected by 
centrifugation at 5000 to 6000 rpm for is min at 4°C (Atalla et al.,2009). 
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2.6 Application of Unease 
The most commercial of uricase application is as an enzyme participating in the 
purine breakdown pathway, catalyzing the oxidation of uric acid in the presence of 
oxygen to allantoin and hydrogen peroxide (Anderson and Vijayakumar, 2011). It has 
beneficial uses both in vitro and in vivo. Beside that, uricase is useful for enzymatic 
determination of urate in clinical analysis by coupling with 4-aminoantipyrine-
peroxidase system (Lotfy, 2008). Determining the urate concentration in blood and urine 
is required for the diagnosis of gout as urate accumulation is a causative factor of gout in 
humans.
The first important application discovered for uricase was in Clinical 
biochemistry as diagnostic reagent for measurement of uric acid in blood and other 
biological fluids (Atalla et al., 2009). Uricase acts as a catalyst in the enzymatic 
oxidation of uric acid to allantoin, a readily excreted metabolite that is five- to 10-fold 
more soluble than uric acid. It is an endogenous enzyme in most mammals, but not in 
humans (Pui etal., 2001). 
Anderson and Vijayakumar (2011) investigated the purification and optimization 
of uricase for protein structure analysis and to carry out animal studies in the future for 
drug development. Lotfy (2008) stated that uricase also can be used as protein drug for 
treatment of hyperuricemja as Rasburicase.
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CHAPTER 3. 
3.0 METHODOLOGY 
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